Panadol manufacturer GSK to exit Nigeria after 51 years of operations GlaxoSmithKline (GSK), the renowned British pharmaceutical company, has revealed its decision to cease operations in Nigeria after a successful presence of 51 years. The company plans to discontinue its prescription medicines and vaccines in the country, transitioning to a third-party direct distribution model for their pharmaceutical products. READ ALSO: Danish company to boost dairy farming in Nigeria In a statement sent to the Nigerian Exchange Limited, GSK stated that it is currently in discussions with its advisors to determine the appropriate course of action. Additionally,...